U.S. stock movement | BioNTech fell over 6%, news reports that Pfizer seeks to sell its stake to cash out over $500 million

LB Select
2025.11.13 14:46
portai
I'm PortAI, I can summarize articles.

Biotechnology company BioNTech (BNTX.US) fell over 6% in early trading, reporting at $104.7. According to sources, Pfizer is seeking to sell its remaining stake in its COVID-19 vaccine partner BioNTech. This equity sale is expected to bring Pfizer up to approximately $508 million in revenue. BioNTech stated that its collaboration with Pfizer remains unchanged and will not comment on any capital market activities of Pfizer

Biotechnology company BioNTech (BNTX.US) fell over 6% in early trading, reporting $104.7. According to insiders, Pfizer is seeking to sell its remaining stake in its COVID-19 vaccine partner BioNTech. This equity sale is expected to bring Pfizer up to approximately $508 million in revenue. BioNTech stated that its collaboration with Pfizer remains unchanged and will not comment on any capital market activities of Pfizer

Source: LB Select The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.